New Workflow Streamlines Protein Structural Analysis and Supports the Growing Role of AI in Drug Discovery

Half Moon Bay, CA – May 7, 2025

Advancing structural biology research with the GenNext AutoFox® Protein Footprinting System and Agilent 6560 Ion Mobility Quadrupole Time-of-Flight (IM-QTOF) LC/MS system

Half Moon Bay, CA – September 10, 2024

Together, the companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics.

Half Moon Bay, CA and Framingham, MA – September 14, 2023

The new AutoFox® System promises to deliver hands-free, high-throughput Hydroxyl Radical Protein Footprinting for sophisticated Higher Order Structural (HOS) analysis.

Half Moon Bay, CA – September 5, 2023

From the keynote address to luncheon presentations and posters, CASSS MS delegates will be exposed to the latest advancements in technology for modern Higher Order Structural analysis.

Half Moon Bay, CA – September 5, 2023

Combining forces to provide best-in-class pharmaceutical functional and structural analysis for allosteric and monoclonal antibody therapeutics.

HALF MOON BAY, Calif. – May 17, 2023

An exclusive distribution agreement is in place with Worldwide Technology (S.H.) Co., Ltd.

​HALF MOON BAY, Calif. – April 28, 2023

Professor Jones will lead the development of protein footprinting technology to study protein interactions of in vivo membrane proteins.

HALF MOON BAY, Calif. – January 11, 2023

Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise.

Half Moon Bay, CA. – January 10, 2023

Company will use the award to further develop scientific instruments, software, and services that ultimately improve the safety, stability, and effectiveness of biotherapeutics.

HALF MOON BAY, Calif. – October 26, 2022

Kiko Tech, a premier distributor of state-of-the-art instruments and reagents for pharmaceutical and academic research, will help introduce the Japanese scientific community to the novel Fox™ technology platform.

​HALF MOON BAY, Calif. – May 11, 2022

GenNext will use this award to advance its intellectual property and expertise to develop a fully automated platform that will study drug-induced HOS structure changes within living cells, with its first system designed for in-vivo protein footprinting studies.

HALF MOON BAY, Calif. – March 24, 2022

The United States Patent and Trademark Office (USPTO) has issued GenNext a Patent for Radical Dosimetry for the Analysis of Biopharmaceuticals and Biological Molecules.

HALF MOON BAY, Calif. – December 9, 2021